Paid Clinical Trials Richmond

Discover 586 paid clinical trials in Richmond, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 586

Enlicitide

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Richmond VA, Newport News VA, Norfolk VA, Manassas VAshow 53 more

Code:

NCT06492291

Conditions

Hypercholesterolemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Enlicitide Decanoate

Treosulfan

Recruiting

PHASE1

Sponsor:

medac GmbH

Location:

Richmond VA, New York NY, Columbus OH, Chicago IL

Code:

NCT05534620

Conditions

Acute Myeloid Leukaemia (AML)

Myelodysplastic Syndrome (MDS)

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Treosulfan

Fludarabine

GIM-122

Recruiting

PHASE1

PHASE2

Sponsor:

Georgiamune Inc

Location:

Richmond VA, New Brunswick NJ, Louisville KY, Nashville TNshow 5 more

Code:

NCT06028074

Conditions

Advanced Solid Malignancies

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

GIM122

Lumateperone

Recruiting

PHASE3

Sponsor:

Intra-Cellular Therapies, Inc.

Location:

Richmond VA, Kinston NC, Staten Island NY, Bronx NYshow 30 more

Code:

NCT06706674

Conditions

Irritability Associated With Autism Spectrum Disorder

Eligibility Criteria

Sex: All

Age: 5 - 17

Healthy Volunteers: Not accepted

Interventions

Lumateperone high dose

Lumateperone low dose

Placebo

Rotigotine with Behavioral Therapy

Recruiting

PHASE2

Sponsor:

Virginia Commonwealth University

Location:

Richmond VA

Code:

NCT05886582

Conditions

Substance-Related Disorders

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Rotigotine Transdermal System [Neupro]

Placebo

Talquetamab, Daratumumab, Pomalidomide

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Richmond VA, Charlottesville VA, Washington DC, Baltimore MDshow 29 more

Code:

NCT05455320

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Talquetamab

Daratumumab

Pomalidomide

Dexamethasone

Bleximenib

Recruiting

PHASE1

PHASE2

Sponsor:

Janssen Research & Development, LLC

Location:

Richmond VA, New York NY, Bronx NY, Knoxville TNshow 15 more

Code:

NCT04811560

Conditions

Acute Leukemias

Acute Myeloid Leukemia

Acute Lymphoblastic Leukemia

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Bleximenib

Sotatercept

Recruiting

PHASE2

Sponsor:

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA

Location:

Richmond VA, Falls Church VA, Washington DC, Durham NCshow 49 more

Code:

NCT04945460

Conditions

Hypertension, Pulmonary

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Sotatercept 0.3 mg/kg

Placebo

Sotatercept 0.3 mg/kg escalating to 0.7 mg/kg

Pelacarsen

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Richmond VA, Hopewell VA, Fort Washington MD, Alexandria VAshow 73 more

Code:

NCT06267560

Conditions

Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

TQJ230

Placebo

AB248 & Pembrolizumab

Recruiting

PHASE1

Sponsor:

Asher Biotherapeutics, Inc.

Location:

Richmond VA, Chapel Hill NC, New Brunswick NJ, New York NYshow 10 more

Code:

NCT05653882

Conditions

Solid Tumor

Non Small Cell Lung Cancer

Melanoma

Squamous Cell Carcinoma of Head and Neck

Renal Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AB248

pembrolizumab